Julie Bonnereau
Overview
Explore the profile of Julie Bonnereau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
More S, Bonnereau J, Wouters D, Spotbeen X, Karras P, Rizzollo F, et al.
Sci Adv
. 2024 Oct;
10(42):eadp6164.
PMID: 39413195
A major therapeutic barrier in melanoma is the coexistence of diverse cellular states marked by distinct metabolic traits. Transitioning from a proliferative to an invasive melanoma phenotype is coupled with...
2.
Asesio N, Mhamdi Aloui N, Bonnereau J, Lehmann-Che J, Bouhidel F, Kaci R, et al.
Dig Liver Dis
. 2023 May;
55(8):1105-1113.
PMID: 37142454
Background: Microsatellite instability (MSI) is a negative predictive factor for neoadjuvant chemotherapy in resectable oesogastric adenocarcinoma and a crucial determinant for immunotherapy. We aimed to evaluate reliability of dMMR/MSI status...
3.
Hammoudi N, Hamoudi S, Bonnereau J, Bottois H, Perez K, Bezault M, et al.
Front Immunol
. 2022 Nov;
13:1008456.
PMID: 36439157
Lympho-epithelial interactions between intestinal T resident memory cells (Trm) and the epithelium have been associated with inflammatory bowel disease (IBD) activity. We developed ex vivo autologous organoid-mucosal T cell cocultures...
4.
Bonnereau J, Courau T, Asesio N, Salfati D, Bouhidel F, Corte H, et al.
Gut
. 2022 Jul;
72(4):699-709.
PMID: 35803702
Objective: T cells are major effectors of the antitumoural immune response. Their activation by tumour-associated antigens can unleash their proliferation and cytotoxic functions, leading to tumour cell elimination. However, tumour-related...
5.
Bottois H, Ngollo M, Hammoudi N, Courau T, Bonnereau J, Chardiny V, et al.
Front Immunol
. 2020 Jun;
11:896.
PMID: 32477365
Intestinal tissue-resident memory CD8 T cells (Trm) are non-recirculating effector cells ideally positioned to detect and react to microbial infections in the gut mucosa. There is an emerging understanding of...
6.
Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, et al.
J Immunother Cancer
. 2019 Mar;
7(1):74.
PMID: 30871626
Background: Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant functional assays aimed at studying these failures and the efficacy of cancer immunotherapy in human are scarce. 3D tumor...